Jubilant Ingrevia Limited (BOM:543271)

Market Cap	113.31B
Revenue (ttm)	41.78B
Net Income (ttm)	2.51B
Shares Out	n/a
EPS (ttm)	15.84
PE Ratio	45.11
Forward PE	34.82
Dividend	5.00 (0.71%)
Ex-Dividend Date	Jul 25, 2025

Volume	51,961
Average Volume	133,258
Open	707.40
Previous Close	703.95
Day's Range	693.30 - 718.95
52-Week Range	515.85 - 884.95
Beta	n/a
RSI	56.33
Earnings Date	Jul 15, 2025

About Jubilant Ingrevia

Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition heal...

• Industry: Chemicals and Allied Products
• Founded: 2019
• Employees: 2,283
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543271

Financial Performance

In 2024, Jubilant Ingrevia's revenue was 41.78 billion, an increase of 1.01% compared to the previous year's 41.36 billion. Earnings were 2.51 billion, an increase of 37.34%.